Cargando…
Quantification of Grapiprant and Its Stability Testing under Changing Environmental Conditions
Grapiprant is a new analgesic and anti-inflammatory drug belonging to the piprant class, approved in 2016 by the FDA Veterinary Medicine Center for the treatment of pain and inflammation associated with osteoarthritis in dogs. It acts as a highly selective antagonist of the EP4 receptor, one of the...
Autores principales: | Gumułka, Paweł, Tarsa, Monika, Dąbrowska, Monika, Starek, Małgorzata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687689/ https://www.ncbi.nlm.nih.gov/pubmed/36359341 http://dx.doi.org/10.3390/biomedicines10112821 |
Ejemplares similares
-
Comprehensive Assessment of the Stability of Selected Coxibs in Variable Environmental Conditions along with the Assessment of Their Potential Hepatotoxicity
por: Gumułka, Paweł, et al.
Publicado: (2023) -
Quality Control of the Dietary Supplements Containing Selected Fat-Soluble Vitamins D and K
por: Starek, Małgorzata, et al.
Publicado: (2023) -
Stability of Metronidazole and Its Complexes with Silver(I) Salts under Various Stress Conditions
por: Starek, Małgorzata, et al.
Publicado: (2021) -
Controlled Delivery of Celecoxib—β-Cyclodextrin Complexes from the Nanostructured Titanium Dioxide Layers
por: Jarosz, Magdalena, et al.
Publicado: (2023) -
Grapiprant: A snapshot of the current knowledge
por: Sartini, Irene, et al.
Publicado: (2021)